Cumberland Pharmaceuticals (CPIX) Assets (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Assets of $71.0 million for Q1 2026, down 7.59% sequentially from $76.8 million in Q4 2025, and up 1.51% YoY from $69.9 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Assets (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Assets for 17 years, with the latest figure at $71.0 million in Q1 2026.
- Quarterly Assets rose 1.51% year-over-year to $71.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $71.0 million (up 1.51% YoY) and the FY2025 annual result came in at $76.8 million, up 1.64% from the prior year.
- Assets declined to $71.0 million in Q1 2026 per CPIX's latest filing, from $76.8 million in the prior quarter.
- Over five years, Assets peaked at $96.7 million in Q1 2022 and troughed at $65.9 million in Q3 2025.
- A 5-year average of $81.5 million and a median of $81.5 million in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2025: Assets grew 10.02% in 2022, then fell 14.2% in 2025.
- Over 5 years, Assets stood at $92.9 million in 2022, then retreated by 12.0% to $81.8 million in 2023, then declined by 7.57% to $75.6 million in 2024, then rose by 1.64% to $76.8 million in 2025, then slipped by 7.59% to $71.0 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $71.0 million, $76.8 million, and $65.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 6.18 Bn |
| 10 | Cumberland Pharmaceuticals | 117.01 Mn | 113.14 Mn | - | 62.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.88 Mn |
| Mar 31, 2026 | 71.00 Mn |
| Dec 31, 2025 | 76.82 Mn |
| Sep 30, 2025 | 65.90 Mn |
| Jun 30, 2025 | 67.91 Mn |
| Mar 31, 2025 | 69.94 Mn |
| Dec 31, 2024 | 75.58 Mn |
| Sep 30, 2024 | 76.75 Mn |
| Jun 30, 2024 | 78.52 Mn |
| Mar 31, 2024 | 81.51 Mn |
| Dec 31, 2023 | 81.78 Mn |
| Sep 30, 2023 | 87.75 Mn |
| Jun 30, 2023 | 89.38 Mn |
| Mar 31, 2023 | 89.47 Mn |
| Dec 31, 2022 | 92.93 Mn |
| Sep 30, 2022 | 90.78 Mn |
| Jun 30, 2022 | 92.52 Mn |
| Mar 31, 2022 | 96.70 Mn |
| Dec 31, 2021 | 84.46 Mn |
| Sep 30, 2021 | 87.57 Mn |